P108 Comparison of quality of life (QOL) between adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) and oral uracil/tegafur in high-risk, node-negative breast cancer – A phase III randomized trial (N-SAS BC 01)
Titel:
P108 Comparison of quality of life (QOL) between adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) and oral uracil/tegafur in high-risk, node-negative breast cancer – A phase III randomized trial (N-SAS BC 01)
Auteur:
Makino, H. Shimozuma, K. Watanabe, T. Ohashi, Y. Katsumata, N. Sonoo, H. Takashima, S.